1. European Medical Agency. COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine's benefits currently still outweigh risks – Update. Mar 11, 2021. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits [accessed 3 May 2021].
2. ‘It's a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca's COVID-19 vaccine;Vogel;Science,2021
3. Pathogenesis of heparin-induced thrombocytopenia;Arepally;Transl Res,2020
4. Autoimmune heparin-induced thrombocytopenia;Greinacher;J Thromb Haemost,2017
5. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination;Greinacher;N Engl J Med,2021